NCT Number: NCT00465387
FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study
Falls and osteoporosis-related fractures cause substantial morbidity and mortality in the elderly, and are an increasingly important public health concern. A comprehensive multidisciplinary and integrated community-based approach is needed to identify and manage the population at highest risk of these complications. Unfortunately, current gaps in continuity of care and health intervention result in a sub-optimal state of health service for these individuals. The Falls, Fracture and Osteoporosis Risk Control and Evaluation (FORCE) Study is a two-year randomized controlled trial evaluated on the effect of coordinated community-based, multidisciplinary approach for fall and fracture prevention in Sault Ste. Marie.
Looking for future studies?
Notify MeKey information
Conditions
Age range
55 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
The FORCE partners are a broad collaboration of interested consumers, stakeholders and providers, led by the Algoma Health Unit (AHU) and the Group Health Centre (GHC) - a community-based, not-for-profit, multidisciplinary health organization. Other partners include the multi-agency, consumer-orientated Algoma District Slips, Trips and Falls Committee, the Sault Area Hospital (SAH), the Algoma Community Care Access Centre (ACCAC), and Pharma Companies Alliance (Aventis and Proctor & Gamble), Merck Frosst and Lilly. The Green Shield Foundation has also provided sponsorship.The results of this study might directly benefit up to eight thousand seniors in the district by providing the impetus to integrated, evidence-based health services. Qualitative and quantitative research during this time will also be a unique opportunity to identify the modifiable barriers to the continuity and quality of care in this high-risk population. By involving the community, the project will also educate those at future risk and hopefully prevent disease and complications. Evaluation and research should provide nationally suggestions for better health service delivery.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 55 years of age or older
- independent living within the city of Sault Ste. Marie, Ontario, Canada
- capable of providing informed consent
Exclusion criteria
- not at risk for falls
- unable to give informed consent
Treatment and study plan
Primary outcomes
-
Fall risk management, assessment and management of gate, strength and balance deficits, completion of medication review, including postural hypotension and psychotropic medications as well as the assessment and management of environmental risk factors.
Sponsors and collaborators
Lead sponsor
Group Health Centre
Other
Collaborators
- Algoma Community Care Access Centre
- Eli Lilly and Company
- Merck Frosst Canada Ltd.
- Pharma Companies Alliance (Aventis and Proctor & Gamble)
- Sault Area Hospital
- The Green Shield Foundation
Registry information
Official study title
Falls, Fracture, and Osteoporosis Risk Control Evaluation (FORCE) Study: A Randomized Controlled Trial With Community Partnerships in Northern Ontario
Important dates
- Study start
- 2003
- Study completion
- 2006
- First posted
- Apr 25, 2007
- Registry last updated
- Apr 25, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Osteoporosis Awareness in Chronic Spinal Cord Injury
NCT07725081
Attitudes, Behavior
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsFinding the Optimal Resistance Training Intensity For Your Bones
NCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsTrial of Parkinson's And Zoledronic Acid
NCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsEvaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital
NCT02924545
Bone Diseases, Bone Diseases, Metabolic
Nîmes, France
View Trial Details